GC Therapeutics, Inc.
A Path to SuperCells™ Therapies
GCTx uses synthetic biology to program patient-derived stem cells into any cell type with best-in-class efficiency (up to 10X), speed (up to 100X) and scalability. We dictate cell fates in a single step and have validated cells for many applications. We have also developed SuperCells™ by tailoring cells for specific diseases.
Who We Are
The core technology of GC Therapeutics Inc. (GCTx) was conceived, invented and perfected in Prof. George Church's lab at Harvard Medical School. We are a group of passionate biologists and tissue engineers whose goal is to bring this breakthrough approach to patients.
George Church, Ph.D.
Parastoo Khoshakhlagh, Ph.D.
Chief Executive Officer,
Alex Ng, Ph.D.
Chief Scientific Officer,
Stem Cell Biologist
We are hiring!
Contact us if you are as excited as we are!
Do you have experience in stem cell biology?
Do you have experience in synthetic biology?
Do you have experience in molecular biology?
"Engineering cell types is the key to cell therapies, transplants and testing new drugs"
Evan Appleton, Ph.D.
Machine Learning Fellow
Synthetic biology researchers receive 2018 Massachusetts Life Science Innovation Day prize
Award recognizes TFome platform technology that enables rapid engineering of a broad spectrum of tissue-specific cell types